The Progressive Corporation (PGR)

NASDAQ

$236.18

+$1.33 (0.57%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$234.70$236.50

Open $235.42

52 Week Range

$199.90$292.99

Previous Close $234.85

Market Cap138.48B

Volume2.02M

Avg Volume3.46M

P/E (TTM)12.97

EPS (TTM)$18.21

Dividend / Yield$4.90 (2.07%)

Dividend StreakN/A

Latest Press Releases for The Progressive Corporation

DEC82025

Progressive Announces Dividend Information And 2026 Annual Meeting Record Date

Source: GlobeNewsWire•7 days ago

MAYFIELD VILLAGE, OHIO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- On December 5, 2025, the Board of Directors of The Progressive Corporation (NYSE:PGR) declared an annual common share dividend, in the amount of $13.50 per share, and a quarterly common share ...

NOV192025

Progressive Reports October 2025 Results

Source: GlobeNewsWire•26 days ago

MAYFIELD VILLAGE, OHIO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended October 31, 2025:...

NOV102025

Genentech's Fenebrutinib Shows Unprecedented Positive Phase III Results as the Potential First and Only BTK Inhibitor in Both Relapsing and Primary Progressive Multiple Sclerosis

Source: Business Wire•35 days ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the first Phase III (FENhance 2) of two pivotal, similarly-designed Phase III studies (FENhance 1 and 2) in patien...

NOV42025

FanDuel Casino Expands Progressive Jackpot Offering with Launch of New Feature

Source: PRNewsWire•41 days ago

FanDuel Casino launches new feature that allows players to double their chances to win a jackpot JERSEY CITY, N.J. , Nov. 4, 2025 /PRNewswire/ -- FanDuel, the premier online gaming company in North America, today announced the launch of its new FanDu...

OCT282025

Progressive Announces Investor Relations Call

Source: GlobeNewsWire•48 days ago

MAYFIELD VILLAGE, OHIO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- As previously announced, The Progressive Corporation (NYSE: PGR) will host an Investor Relations conference call on Tuesday, November 4, 2025, beginning at 9:30 a.m. eastern time. This quarter...

OCT202025

Autolus Therapeutics Announces First Patient Dosed in Phase 1 Trial of Obecabtagene Autoleucel (Obe-Cel) in Patients with Progressive Multiple Sclerosis

Source: GlobeNewsWire•56 days ago

LONDON and Gaithersburg, Md., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announc...

OCT152025

Progressive Reports September 2025 Results

Source: GlobeNewsWire•61 days ago

MAYFIELD VILLAGE, OHIO, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The Progressive Corporation (NYSE:PGR) today reported the following results for the month and quarter ended September 30, 2025:...

SEP192025

Stealth BioTherapeutics Announces FDA Accelerated Approval of FORZINITY™ (elamipretide HCl), the First Therapy for Progressive and Life-limiting Ultra-rare Genetic Disease Barth Syndrome

Source: PRNewsWire•87 days ago

NEEDHAM, Mass. , Sept. 19, 2025 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a commercial-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving ...

SEP172025

Progressive Reports August 2025 Results

Source: GlobeNewsWire•89 days ago

MAYFIELD VILLAGE, OHIO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended August 31, 2025:...